These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31271556)

  • 1. Safety and effectiveness of growth hormone therapy in infants with Prader-Willi syndrome younger than 2 years: a prospective study.
    Corripio R; Tubau C; Calvo L; Brun C; Capdevila N; Larramona H; Gabau E
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):879-884. PubMed ID: 31271556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
    Scheermeyer E; Harris M; Hughes I; Crock PA; Ambler G; Verge CF; Bergman P; Werther G; Craig ME; Choong CS; Davies PSW;
    Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.
    Myers SE; Whitman BY; Carrel AL; Moerchen V; Bekx MT; Allen DB
    Am J Med Genet A; 2007 Mar; 143A(5):443-8. PubMed ID: 17103437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably.
    Lindgren AC; Hagenäs L; Müller J; Blichfeldt S; Rosenborg M; Brismar T; Ritzén EM
    Acta Paediatr; 1998 Jan; 87(1):28-31. PubMed ID: 9510443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
    Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
    Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.
    Whitman B; Carrel A; Bekx T; Weber C; Allen D; Myers S
    J Pediatr Endocrinol Metab; 2004 Apr; 17(4):591-600. PubMed ID: 15198290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
    Lindgren AC; Ritzén EM
    Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Mental and Motor Development During 3 Years of GH Treatment in Very Young Children With Prader-Willi Syndrome.
    Donze SH; Damen L; Mahabier EF; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3714-3719. PubMed ID: 30113638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome.
    Oto Y; Tanaka Y; Abe Y; Obata K; Tsuchiya T; Yoshino A; Murakami N; Nagai T
    Am J Med Genet A; 2014 Mar; 164A(3):671-5. PubMed ID: 24443368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi Syndrome.
    Dağdeviren Çakır A; Baş F; Akın O; Şıklar Z; Özcabı B; Berberoğlu M; Kardelen AD; Bayramoğlu E; Poyrazoğlu Ş; Aydın M; Törel Ergür A; Gökşen D; Bolu S; Aycan Z; Tüysüz B; Ercan O; Evliyaoğlu O
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):308-319. PubMed ID: 33565750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of growth hormone treatment in children with Prader-Willi syndrome over a 30-year period: a single tertiary center experience.
    Gamage DS; Ambler G; Chan A; Srinivasan S; Maguire AM; Cho YH
    J Pediatr Endocrinol Metab; 2024 Aug; 37(8):680-685. PubMed ID: 39089289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
    J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.
    Carrel AL; Moerchen V; Myers SE; Bekx MT; Whitman BY; Allen DB
    J Pediatr; 2004 Dec; 145(6):744-9. PubMed ID: 15580194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome.
    Lin HY; Lin SP; Tsai LP; Chao MC; Chen MR; Chuang CK; Huang CY; Tsai FJ; Chou IC; Chiu PC; Huang CH; Yen JL; Lin JL; Kuo PL
    J Chin Med Assoc; 2008 Jun; 71(6):305-9. PubMed ID: 18567561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].
    Lämmer C; Weimann E
    Wien Med Wochenschr; 2007 Feb; 157(3-4):82-8. PubMed ID: 17340066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.